Mucormycosis: An emerging concern of orofacial complication in COVID-19 infection
Coronavirus disease (COVID-19) infection has been seen to be associated with secondary bacterial and fungal infections. Mucormycosis has been increasingly reported in patients with COVID-19 infection, especially those with underlying medical conditions such as diabetes mellitus and on steroid therap...
Saved in:
Main Authors: | Anam Mushtaq (Author), Reshi Iram Shafi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Associated Mucormycosis and Anbarnesa: Concerning about Important Source of Spores
by: Mohsen Pourazizi, et al.
Published: (2022) -
Mucormycosis: A case report of black fungus as COVID-19 complication
by: Prarthana Govil, et al.
Published: (2022) -
Mucormycosis in COVID-19
by: Vasantha Kamath, et al.
Published: (2021) -
COVID-19-associated rhino-mucormycosis and pulmonary aspergillosis infection
by: Jitender Singh, et al.
Published: (2022) -
Dexamethasone induced Sino-orbital Mucormycosis in a Patient Infected with COVID-19
by: Masoud Mardani, et al.
Published: (2022)